sellWeak10b5-1 plan
Rohan Palekar sold $575k of ETNB
Chief Executive Officer at 89bio, Inc.. 52,718 shares at an average of $10.91, traded Apr 1, 2024, filed Apr 3, 2024.
Warning score
14Value
$575k
52,718 shares
Holdings after
459,171
-10% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +19Trade size$575k at market
- +5Share of holdings soldSold 10% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-041024, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 1, 2024 | MOption exercise Common Stock10b5-1 | +25,000 | $1.93 | $48k | 511,889 | Apr 3, 2024 |
| Apr 1, 2024 | SOpen-market sale Common Stock10b5-1 | -52,718 | $10.91 | $575k | 459,171 | Apr 3, 2024 |
| Apr 1, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 120,231 | Apr 3, 2024 |
Related signals
Other insiders at 89bio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 5Weak | 89bio, Inc. | Quoc Le-Nguyen See Remarks | $115k 10,461 shares | -3% | |
| 4Weak | 89bio, Inc. | Quoc Le-Nguyen See Remarks | $91k 15,329 shares | -4% | |
| 54Moderate | 89bio, Inc. | Ra Capital Management, L.p. director, owner | $50M 5,714,285 shares | +41% | |
| 48Moderate | 89bio, Inc. | Charles McWherter director | $100k 15,000 shares | +150% | |
| 3Weak | 89bio, Inc. | Quoc Le-Nguyen See Remarks | $71k 10,963 shares | -4% | |
| 44Moderate | 89bio, Inc. | Rohan Palekar Chief Executive Officer | $39k 5,000 shares | +1% | |
| 40Moderate | 89bio, Inc. | Charles McWherter director | $80k 10,000 shares | - | |
| 42Moderate | 89bio, Inc. | Rohan Palekar Chief Executive Officer | $84k 10,000 shares | +2% | |
| 13Weak | 89bio, Inc. | Quoc Le-Nguyen See Remarks | $227k 27,955 shares | -13% | |
| 38Weak | ETNBbuy 89bio, Inc. | Ra Capital Management, L.p. director, owner | $21M 1,350,000 shares | +12% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.